Morphine Sulfate
NDC Package 17856-0518-3

11-digit billing NDC: 17856051803

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Morphine Sulfate is oral Solution 2 mg/mL and 4 mg/mL is indicated for the management of •adults with acute and chronic pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Marketed by Atlantic Biologicals Corp., this product is identified by NDC 17856-0518 and is authorized under FDA application NDA022195.

Identification & Billing

NDC Package Code
17856-0518-3
Package Description
120 SYRINGE in 1 BOX, UNIT-DOSE / .5 mL in 1 SYRINGE (17856-0518-4)
Product Code
11-Digit Billing Format
17856051803
RxNorm Crosswalk
  • RxCUI: 892625 - morphine sulfate 20 MG in 1 mL Concentrate for Oral Solution
  • RxCUI: 892625 - morphine sulfate 20 MG/ML Oral Solution
  • RxCUI: 892625 - morphine sulfate 10 MG per 0.5 ML Concentrate for Oral Solution
  • RxCUI: 892625 - morphine sulfate 100 MG per 5 ML Concentrate for Oral Solution
  • RxCUI: 892625 - morphine sulfate 20 MG/ML Concentrate for Oral Solution

Clinical Specifications

Proprietary Name
Morphine Sulfate
Dosage Form
-
Usage Information
Morphine Sulfate Oral Solution 2 mg/mL and 4 mg/mL is indicated for the management of •adults with acute and chronic pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. •pediatric patients 2 years of age and older with acute pain severe enough to require an opioid analgesic and for which alternativetreatments are inadequate.Morphine Sulfate Oral Solution 20 mg/mL is indicated for the relief of acute and chronic pain in opioid-tolerant adult patients.Limitations of Use:Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see Warnings and Precautions (5.2)], reserve Morphine Sulfate Oral Solution for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]:•Have not been tolerated, or are not expected to be tolerated,•Have not provided adequate analgesia, or are not expected to provide adequate analgesia.

Regulatory & Marketing

Labeler Name
Atlantic Biologicals Corp.
FDA Application #
NDA022195
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-17-2008
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (17856-0518). Click a package code to view its specific billing and regulatory data.

60 SYRINGE in 1 BOX, UNIT-DOSE / .5 mL in 1 SYRINGE (17856-0518-2)
30 SYRINGE in 1 BOX, UNIT-DOSE / .25 mL in 1 SYRINGE (17856-0518-5)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 17856-0518-3 identifies a specific commercial package of 120 syringe in 1 box, unit-dose / .5 ml in 1 syringe (17856-0518-4) of Morphine Sulfate, labeled by Atlantic Biologicals Corp.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Atlantic Biologicals Corp. on March 17, 2008. The current certification is valid through December 31, 2024.

How is this Atlantic Biologicals Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856051803. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
17856-0518-3
11-Digit CMS (5-4-2)
17856-0518-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.